Last Updated on Nov 04, 2014

Latest Publications and Research on Fibroscan for Fatty Liver Cirrhosis and Fibrosis

Clin Res Hepatol Gastroenterol  2020 Jan 25  

Transient elastography for assessment of fibrosis and steatosis of liver grafts from brain-death donors.

Liu WY, Wang JH, Guo Y, Wang X, Wu XD, Xu CS, Zhao Y, Zang YJ

An objective and accurate evaluation of liver grafts is required to improve the prognosis of liver transplant recipients and to increase the number of... Read More

Source: PubMed


J Assoc Physicians India    

Correlation of Fibroscan with FIB-4 index and APRI for Assessment of Liver Fibrosis in patients with Nonalcoholic Fatty Liver Disease.

Soni A, Tripathi BK

... Read More

Source: PubMed

Lancet Gastroenterol Hepatol  2020 Jan 15  

Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.

Abeysekera KWM, Fernandes GS, Hammerton G, Portal AJ, Gordon FH, Heron J, Hickman M

The estimated worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) in adults is 25%; however, prevalence in young adults remains unclear.... Read More

Source: PubMed

Obes Surg  2020 Jan 18  

Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.

Kao WY, Chang IW, Chen CL, Su CW, Fang SU, Tang JH, Chang CC, Chang YJ, Wang W

The prevalence rate of nonalcoholic fatty liver disease (NAFLD) has been reported in 74 to 90% of morbidly obese patients. This study aims to develop ... Read More

Source: PubMed

J. Gastroenterol. Hepatol.  2020 Jan 06  

Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one.

Chuah KH, Lai LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK

Repeating liver stiffness measurement (LSM) was recently reported to improve accuracy to diagnose fibrosis stage in patients with non-alcoholic fatty ... Read More

Source: PubMed

Clin Res Hepatol Gastroenterol  2020 Jan 25  

Transient elastography for assessment of fibrosis and steatosis of liver grafts from brain-death donors.

Liu WY, Wang JH, Guo Y, Wang X, Wu XD, Xu CS, Zhao Y, Zang YJ

An objective and accurate evaluation of liver grafts is required to improve the prognosis of liver transplant recipients and to increase the number of... Read More

Source: PubMed

J Assoc Physicians India    

Correlation of Fibroscan with FIB-4 index and APRI for Assessment of Liver Fibrosis in patients with Nonalcoholic Fatty Liver Disease.

Soni A, Tripathi BK

... Read More

Source: PubMed

Lancet Gastroenterol Hepatol  2020 Jan 15  

Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.

Abeysekera KWM, Fernandes GS, Hammerton G, Portal AJ, Gordon FH, Heron J, Hickman M

The estimated worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) in adults is 25%; however, prevalence in young adults remains unclear.... Read More

Source: PubMed

Obes Surg  2020 Jan 18  

Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.

Kao WY, Chang IW, Chen CL, Su CW, Fang SU, Tang JH, Chang CC, Chang YJ, Wang W

The prevalence rate of nonalcoholic fatty liver disease (NAFLD) has been reported in 74 to 90% of morbidly obese patients. This study aims to develop ... Read More

Source: PubMed

J. Gastroenterol. Hepatol.  2020 Jan 06  

Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one.

Chuah KH, Lai LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK

Repeating liver stiffness measurement (LSM) was recently reported to improve accuracy to diagnose fibrosis stage in patients with non-alcoholic fatty ... Read More

Source: PubMed

Most Popular on Medindia